+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chromosomal microarray analysis of Bulgarian patients with epilepsy and intellectual disability

Chromosomal microarray analysis of Bulgarian patients with epilepsy and intellectual disability

Gene 667: 45-55

High resolution chromosomal microarray analysis (CMA) has facilitated the identification of small chromosomal rearrangements throughout the genome, associated with various neurodevelopmental phenotypes, including ID/DD. Recently, it became evident that intellectual disability (ID)/developmental delay (DD) can occur with associated co-morbidities like epileptic seizures, autism and additional congenital anomalies. These observations require whole genome approach in order to detect the genetic causes of these complex disorders. In this study, we examined 92 patients of Bulgarian origin at age between 1 and 22 years with ID, generalized epilepsy, autistic signs and congenital anomalies. CMA was carried out using SurePrint G3 Human CGH Microarray Kit, 4 × 180 K and SurePrint G3 Unrestricted CGH ISCA v2, 4 × 180 K oligo platforms. Referral indications for selection of the patients were the presence of generalized refractory seizures disorders and co-morbid ID. Clearly pathogenic copy number variations (CNVs) were detected in eight patients (8.7%) from our cohort. Additionally, possibly pathogenic rearrangements of unclear clinical significance were detected in six individuals (6.5%), which make for an overall diagnostic yield of 15.2% among our cohort of patients. We report here the patients with clearly pathogenic CNVs, discuss the potential causality of the possibly pathogenic CNVs and make genotype - phenotype correlations. One novel possibly pathogenic heterozygous deletion in 15q22.31 region was detected in a case with ID/DD. Additionally, whole APBA2 gene duplication in 15q13.1 was found in three generations of a family with epilepsy, ID and psychiatric abnormalities. The results from this study allow us to define the genetic diagnosis in a subset of Bulgarian patients and improve the genetic counseling of the affected families. To our knowledge, this is the first aCGH evaluation of a Bulgarian cohort of children with epilepsy and ID so far.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054318362

Download citation: RISBibTeXText

PMID: 29753047

DOI: 10.1016/j.gene.2018.05.015

Related references

Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability. Yonsei Medical Journal 59(3): 431-437, 2018

Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability. Molecular Diagnosis and Therapy 22(1): 129-138, 2018

Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions. Bmc Medical Genomics 11(1): 49, 2018

Chromosomal microarray analysis in peruvian children with delayed psychomotor development or intellectual disability. Revista Peruana de Medicina Experimental Y Salud Publica 34(3): 572-574, 2017

Application of chromosomal microarray analysis for the diagnosis of children with intellectual disability/developmental delay and a normal karytype. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 34(2): 169-172, 2017

Chromosomal microaberrations in patients with epilepsy, intellectual disability, and congenital anomalies. Clinical Genetics 86(4): 361-366, 2014

Chromosomal microarray in clinical diagnosis: a study of 337 patients with congenital anomalies and developmental delays or intellectual disability. Croatian Medical Journal 58(3): 231-238, 2017

A non-syndromic intellectual disability associated with a de novo microdeletion at 7q and 18p, microduplication at Xp, and 18q partial trisomy detected using chromosomal microarray analysis approach. Molecular Cytogenetics 7: 44, 2014

Special Report: Chromosomal Microarray for the Genetic Evaluation of Patients With Global Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder. Technology Evaluation Center Assessment Program. Executive Summary 30(2): 1-4, 2015

Chromosomal Microarray Testing in 42 Korean Patients with Unexplained Developmental Delay, Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies. Genomics and Informatics 15(3): 82-86, 2017

Changing interpretation of chromosomal microarray over time in a community cohort with intellectual disability. American Journal of Medical Genetics. Part a 164a(2): 377-385, 2014

Chromosomal microarray among children with intellectual disability: a useful diagnostic tool for the clinical geneticist. Developmental Medicine and Child Neurology 56(3): 290, 2014

Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability. Annals of Laboratory Medicine 38(5): 473-480, 2018

Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China. Pediatrics and Neonatology 60(1): 35-42, 2019

Analysis of chromosomal abnormalities by CGH-array in patients with dysmorphic and intellectual disability with normal karyotype. Einstein 14(1): 30-34, 2016